The global Paroxysmal Nocturnal Hemoglobinuria Drug market is expected to rise with an impressive CAGR and generate the highest revenue by 2032. Zion Market Research in its latest report published this information. The report is titled “Paroxysmal Nocturnal Hemoglobinuria Drug Market By Treatment (Medication, Supplements, Blood Transfusion, And Bone Marrow Transplant), By Drugs (Eculizumab, Ravulizumab, And Others), […]